Boditech Med Inc. (KOSDAQ:206640)
13,530
+120 (0.89%)
At close: Dec 5, 2025
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 294.73 billion as of December 5, 2025. Its market cap has decreased by -19.79% in one year.
Market Cap
294.73B
Enterprise Value
290.81B
Revenue
151.75B
Ranking
n/a
PE Ratio
10.82
Stock Price
13,530.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 294.73B, an increase of 946.92%. That is a compound annual growth rate of 25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 294.73B | -20.08% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | 545.55B | 146.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |